Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The looming threat of a TikTok ban is set to become reality, though some pharma marketers view the situation as an opportunity.

Some members of President-elect Donald Trump’s inner circle are gearing up to battle 'Big Food,' or the companies that make most of the food and beverages consumed in the United States.

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

As the nation braces for potential policy shifts under President-elect Donald Trump’s “Make America Healthy Again” mantra, the nation’s most populous state and largest health care market is preparing ...

Johnson & Johnson announced it will buy Intra-Cellular Therapies for $14.6 billion. Biogen said it will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece.

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.